Page last updated: 2024-08-21

lauryl gallate and Disease Models, Animal

lauryl gallate has been researched along with Disease Models, Animal in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chorilli, M; Conçolaro, RS; da Silva, PB; Fusco Almeida, AM; Lourencetti, NMS; Mendes Giannini, MJS; Nazaré, AC; Oliveira, LR; Polaquini, CR; Regasini, LO; Scorzoni, L; Singulani, JL; Victorelli, FD1
Campbell, KC; Hughes, LF; Larsen, DL; Meech, RP; Rybak, LP1

Other Studies

2 other study(ies) available for lauryl gallate and Disease Models, Animal

ArticleYear
Potential of the association of dodecyl gallate with nanostructured lipid system as a treatment for paracoccidioidomycosis: In vitro and in vivo efficacy and toxicity.
    International journal of pharmaceutics, 2018, Aug-25, Volume: 547, Issue:1-2

    Topics: Animals; Antifungal Agents; Biological Availability; Cell Line; Disease Models, Animal; Female; Fibroblasts; Gallic Acid; Humans; Inhibitory Concentration 50; Lipids; Lung; Male; Mice; Mice, Inbred BALB C; Nanoparticles; Paracoccidioides; Paracoccidioidomycosis; Treatment Outcome; Zebrafish

2018
Glutathione ester but not glutathione protects against cisplatin-induced ototoxicity in a rat model.
    Journal of the American Academy of Audiology, 2003, Volume: 14, Issue:3

    Topics: Acoustic Stimulation; Animals; Antineoplastic Agents; Cisplatin; Disease Models, Animal; Evoked Potentials, Auditory, Brain Stem; Gallic Acid; Glutathione; Hair Cells, Auditory, Outer; Hearing Loss; Inactivation, Metabolic; Injections, Intraperitoneal; Rats

2003